Claude

Know the Business

Everest Industries is a 91-year-old Indian building materials company running three distinct businesses under one roof: fibre cement roofing sheets (rural, low-margin, commodity), fibre cement boards and panels (urban, higher-margin, growing category), and pre-engineered steel buildings (project-based, lumpy). The market is most likely overestimating how quickly Boards & Panels can pull the consolidated margin profile up, and underestimating how much the legacy roofing business and PEB working capital swings can drag returns down during weak cycles. Trading below book value with negative TTM earnings, this is a business where operating leverage cuts both ways.

How This Business Actually Works

The economic engine is simple in concept but tricky in execution. Everest buys three raw materials it cannot control – chrysotile asbestos fibre (imported, few global suppliers, Russia-dependent), cement, and steel – and sells three products into markets with very different demand drivers.

Roofing is the legacy cash cow – fibre cement sheets sold through 12,000+ channel partners into 100,000+ villages. Volume growth is near-zero (0.5-1% CAGR), so the entire game is pricing power versus raw material cost. When chrysotile fibre prices spike (as they did from FY2022-FY2025 due to Russia-Ukraine disruption), margins collapse because Everest cannot fully pass through costs to price-sensitive rural buyers. The fibre cement roofing market is approximately Rs 6,200 Cr, growing at just 3% in value terms.

Boards & Panels is the growth story – fibre cement boards replacing traditional brick, gypsum, and ACP in dry construction. The market is growing at 12.5% CAGR, total industry capacity is around 9-12 lakh MT, and Everest has ~2.15 lakh MT capacity (including Mysore plant commissioned in 2024). Exports contribute ~25-29% of Boards revenue. This segment has genuine category-creation potential as India shifts toward faster, modular construction for data centres, commercial spaces, and affordable housing.

Pre-Engineered Steel Buildings (PEB) is a project business with 72,000 MT capacity. Revenue is lumpy, order-book-driven, and margin-volatile. Steel price movements flow directly to margins on fixed-price contracts.

The fundamental tension: Roofing generates most of the revenue but minimal profit; Boards & Panels generates the profit but is still sub-scale; PEB is a capital-intensive swing factor. The company is trying to transition from a commodity roofing business to a value-added building solutions provider, but the transition is incomplete and painful.

Margins have ranged from 2% to 9% over 11 years, with no sustained upward trend despite the stated strategy of moving up the value chain. The best year (FY2021, 9% OPM) was a pandemic anomaly with low input costs and pent-up demand. The worst (FY2025, 2% OPM) reflected compounding pain of chrysotile inflation, weak rural demand, and PEB execution delays.

The Playing Field

Ramco Industries is the closest pure-play competitor, with a 4x larger market cap, better ROE (4.4% vs -1.1%), and similar ROCE compression in FY2025. Ramco's scale advantage in southern India gives it a structural distribution edge.

Visaka Industries mirrors Everest's diversification strategy but also has yarn and solar businesses. Visaka's V-Next boards brand holds the domestic #1 position in fibre cement boards with 3.2 lakh MT capacity exceeding Everest's ~2.15 lakh MT. Visaka is also in loss territory (ROE -0.25%), confirming this is industry-wide pain.

HIL Ltd (CK Birla group) is the premium benchmark – consistently higher ROCE (15%), stronger brand in pipes and boards, market cap 10x Everest's. HIL shows what "good" looks like in building products: diversification that actually works, with pipes providing stable margins.

The key takeaway: Everest is a mid-tier player without a clear cost or brand moat. In roofing, it competes on distribution reach. In boards, it is #2 or #3 behind Visaka and potentially international entrants. In PEB, it faces dozens of regional fabricators. No segment has pricing power.

Is This Business Cyclical?

This business is deeply cyclical, but the cycles come from different directions in each segment, making the consolidated P&L harder to read than it appears.

Where the cycle hits:

Roofing (rural demand + input costs): Monsoon quality, rural income, and government housing spend drive volumes. Chrysotile fibre prices (imported, USD-denominated, concentrated supply from Russia/Brazil/Kazakhstan) drive costs. FY2017: demonetization crushed rural demand. FY2020: COVID lockdowns. FY2023-FY2025: Russia-Ukraine war spiked chrysotile prices while rural demand softened.

PEB (capex cycle + steel prices): Warehousing and industrial capex drive orders. Steel price swings hit margins on fixed-price contracts with 6-12 month execution timelines.

Boards & Panels (urban construction cycle): More stable than roofing but still tied to real estate and commercial construction activity. Export demand adds currency volatility.

Working capital is the hidden cyclical amplifier. Inventory days ballooned from 142 (FY2021) to 194 (FY2023) as the company stockpiled chrysotile during supply disruptions. The cash conversion cycle swung from 68 days to 154 days, destroying free cash flow. FCF went from +Rs 248 Cr (FY2021) to -Rs 201 Cr (FY2023) and -Rs 160 Cr (FY2025).

The Metrics That Actually Matter

1. Operating Margin is the single most important number. In a commodity business with 2-9% OPM range, small changes in input costs or product mix swing the P&L from profit to loss. A 1pp OPM improvement on ~Rs 1,575 Cr revenue adds Rs 15.75 Cr to EBIT – roughly 50% of FY2025 operating income.

2. ROCE: Everest has earned above its cost of capital (~12%) in only 4 of 11 years (FY2015, FY2018, FY2019, FY2021). The median ROCE is ~11%, barely at the hurdle. This is not a wealth-creating business on a through-cycle basis.

3. Cash Conversion Cycle: The inventory-heavy nature (chrysotile stockpiling, steel for PEB) means CCC is the leading indicator of cash flow stress. When CCC exceeds 120 days, expect negative FCF.

4. Interest Coverage: Went from 24.8x (FY2021) to -0.39x (FY2025). The Mysore Boards plant (subsidiary Everest Buildpro) added Rs 94.5 Cr in long-term debt. Net debt rose to Rs 164 Cr. While not alarming versus Rs 597 Cr equity, the trajectory matters when operating income is collapsing.

5. Boards & Panels revenue share: Every percentage point shift from Roofing to B&P structurally improves blended margins. The Mysore plant commissioning was designed to accelerate this. Watch whether B&P share crosses 25-30% in the next 2-3 years.

What I'd Tell a Young Analyst

Do not anchor to the peak. FY2019 and FY2021 are not the normal state. They were cyclical peaks driven by temporarily favourable input costs and demand. The "normalized" OPM is closer to 4-5%, not 7-9%.

The chrysotile dependency is the risk most people underweight. The company sources chrysotile fibre from a handful of suppliers, several in Russia. There is no liquid hedging market. A supply disruption or regulatory change (chrysotile asbestos faces periodic ban campaigns globally) could be existential for the roofing business. The company is diversifying suppliers but the input is inherently concentrated.

The Boards & Panels transition is real but early. The new Mysore plant and export growth are genuine positives. Fibre cement boards replacing traditional materials is a multi-decade secular trend in India. But Everest is not the clear market leader – Visaka's V-Next and potential international entrants like James Hardie could capture more of this growth. Watch for B&P crossing 30% of consolidated revenue as the proof point.

The balance sheet is the cushion, not the catalyst. At 0.92x P/B with Rs 597 Cr equity, downside is partially protected by asset value. But book value does not compound when ROCE is 1%.

What would change the thesis: (1) Sustained B&P revenue share above 30% with segment margins above 10%. (2) Chrysotile price collapse or successful alternative fibre development restoring roofing margins. (3) PEB order book exceeding Rs 400 Cr with improving execution. (4) Conversely, an asbestos ban in India or further chrysotile supply disruption would be devastating.